Phase 1/2 study assessing the safety and efficacy of dabrafenib and trametinib combination therapy in Japanese patients with BRAF V600 mutation-positive advanced cutaneous melanoma.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Yutaka Fujiwara Naoya Yamazaki |
| Publication date | February 5, 2018 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |